Article By Diseases | Bentham Science

Articles by Disease (Dyskinesias)

Therapeutic Strategies for Alzheimer's and Parkinson's Diseases by Means of Drug Delivery Systems

Journal: Current Medicinal Chemistry
Volume: 23
Page: 3618-3631
Author(s): S. Cunha, M. H. Amaral, J. M. Sousa Lobo and A. C. Silva

Recent Developments in Group I Metabotropic Glutamate Receptor Allosteric Modulators for the Treatment of Psychiatric and Neurological Disorders (2014-May 2015)

Journal: Current Topics in Medicinal Chemistry
Volume: 16
Page: 3470-3526
Author(s): Guiying Li, Morten Jorgensen, Brian M. Campbell and Dario Doller

Inhibitors of Glycine Transporter-1: Potential Therapeutics for the Treatment of CNS Disorders

Journal: Current Topics in Medicinal Chemistry
Volume: 16
Page: 3404-3437
Author(s): Christopher L. Cioffi and Peter R. Guzzo

Dopamine Targeting Drugs for the Treatment of Schizophrenia: Past, Present and Future

Journal: Current Topics in Medicinal Chemistry
Volume: 16
Page: 3385-3403
Author(s): Peng Li, Gretchen L. Snyder and Kimberly E. Vanover

Adamantane – A Lead Structure for Drugs in Clinical Practice

Journal: Current Medicinal Chemistry
Volume: 23
Page: 3245-3266
Author(s): Katarina Spilovska, Filip Zemek, Jan Korabecny, Eugenie Nepovimova, Ondrej Soukup, Manfred Windisch and Kamil Kuca

Parkinson's Disease, Diabetes and Cognitive Impairment

Journal: Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued)
Volume: 10
Page: 11-21
Author(s): Mohammad R. Ashraghi, Gennaro Pagano, Sotirios Polychronis, Flavia Niccolini and Marios Politis

Pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidines and Structurally Simplified Analogs. Chemistry and SAR Profile as Adenosine Receptor Antagonists

Journal: Current Topics in Medicinal Chemistry
Volume: 16
Page: 3224-3257
Author(s): Sara Redenti, Antonella Ciancetta, Giorgia Pastorin, Barbara Cacciari, Stefano Moro, Giampiero Spalluto and Stephanie Federico